 |
|
|
| |
HEALTH-RELATED QUALITY OF LIFE (HRQOL) BEFORE AND AFTER TREATMENT OF GENOTYPE 1 (GT1) INFECTION WITH ELBASVIR/GRAZOPREVIR (EBR/GZR): RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)
|
| |
| |
EASL 2020 Aug 27-29
Reported by Jules Levin
Dietrich Huppe1, Albrecht Stoehr2, Hartwig Klinker3, Renate Heyne4, Christine John5, Karl-Georg Simon6, Manfred Bilzer7, Veronika Guenther8, Markus Becker-Camps8, Vanessa Witte8, Markus Cornberg9
1Gastroenterologische Gemeinschaftspraxis, Herne; 2Institute for Interdisciplinary Medicine, Hamburg; 3University Hospital Wurzburg, Wurzburg; 4Leberzentrum am Checkpoint, Berlin; 5Private Practice of Internal Medicine, Berlin; 6MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen; 7Bilzer Consulting, Munchen; 8MSD Sharp & Dohme GmbH, Haar; 9Hannover Medical School, Hannover
|
| |
|
|
|
|
|
